Literature DB >> 10549507

Topotecan--a new treatment option in the therapy of brain metastases of lung cancer.

W Schütte1, C Manegold, J V von Pawel, J Lan, B Schäfer, S Kaubitzsch, H J Staab.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10549507     DOI： 10.1159/000061219

Source DB:  PubMed          Journal:  Front Radiat Ther Oncol        ISSN： 0071-9676


× No keyword cloud information.
  3 in total

1.  The combination topotecan, temozolomide and dexamethasone associated with radiotherapy as treatment of central nervous system myeloma relapse.

Authors:  Ombretta Annibali; Carolina Nobile; Rosa Greco; Francesco Cellini; Carlo Cosimo Quattrocchi; Maria Cristina Tirindelli; Maria Teresa Petrucci; Giuseppe Avvisati
Journal:  Int J Hematol       Date:  2009-03-26       Impact factor: 2.490

2.  Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer.

Authors:  Xiao-Hui Ge; Qiang Lin; Xiao-Cang Ren; Yue-E Liu; Xue-Ji Chen; Dong-Ying Wang; Yong-Qiang Wang; Bin Cao; Zhi-Gang Li; Miao-Ling Liu
Journal:  Radiat Oncol       Date:  2013-10-14       Impact factor: 3.481

3.  A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer.

Authors:  T Neuhaus; Y Ko; R P Muller; G G Grabenbauer; J P Hedde; H Schueller; M Kocher; S Stier; R Fietkau
Journal:  Br J Cancer       Date:  2009-01-06       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.